Welcome to our dedicated page for HALEON PLC SEC filings (Ticker: HLNCF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The HLNCF SEC filings page on Stock Titan provides access to U.S. regulatory disclosures related to Haleon plc, which files as a foreign private issuer and is listed on the London Stock Exchange and New York Stock Exchange under the symbol HLN. These filings are submitted on Form 20-F for annual reporting and Form 6-K for current reports under the Securities Exchange Act of 1934.
Haleon’s Form 6-K filings cover several important areas for investors. Some reports focus on operating model and strategy, such as the announcement of the evolution of its operating model in support of its "Win as One" strategy. These documents describe the creation of roles like Chief Growth Officer and Chief Transformation Officer, the formation of regional Operating Units, and the responsibilities of global functions.
Other 6-K filings relate to Director/PDMR Shareholding. These provide notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities (PDMRs) under the UK Market Abuse Regulation, including acquisitions of partnership shares and awards of matching shares under Haleon’s Share Reward Plan, with details on the financial instruments and trading venue.
Haleon also files 6-K reports on Total Voting Rights and Capital, which set out the number of issued ordinary shares of £0.01 each, treasury shares and ordinary shares with voting rights. This information is relevant for shareholders and others with notification obligations under the UK FCA’s Disclosure Guidance and Transparency Rules.
On Stock Titan, users can review these Haleon filings in one place, with AI-powered summaries that explain the key points of each document, from strategic changes to insider transactions and share capital updates, helping to make complex regulatory text more accessible.
Haleon plc announced the purchase of 4,150,000 ordinary shares of £0.01 each on 19 September 2025 under the second tranche of its share buyback programme announced 31 July 2025. The shares were purchased on the London Stock Exchange and CBOE (UK)/CXE across the session; a full breakdown of individual trades is provided via the Company link. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 23,037,545 are treasury shares, leaving 8,929,316,103 voting shares.
Haleon plc reports it purchased 4,314,000 ordinary shares of £0.01 each under the second tranche of its buyback programme announced 31 July 2025. The company intends to hold the purchased shares as treasury shares. After settlement the company's registered share capital is 8,952,353,648 ordinary shares, of which 18,887,545 are treasury shares, leaving 8,933,466,103 ordinary shares with voting rights. Shareholders may use the voting-rights figure to determine notification obligations under the FCA Disclosure Guidance and Transparency Rules. A full breakdown of individual trades is available via the provided RNS link and on the company website.
Haleon plc completed a tranche of its share buyback programme, acquiring 5,214,540 ordinary shares (â£0.01 each) on 17 September 2025. The company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 14,573,545 are held in treasury, leaving 8,937,780,103 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on the company's investor website.
Haleon plc announced the purchase of 5,357,044 ordinary shares of £0.01 each under the second tranche of its buyback programme. The company will hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 9,359,005 are held in treasury, leaving 8,942,994,643 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided link and on the company's investor website. The announcement notes this does not constitute an offer for securities.
Haleon plc purchased 1,500,000 ordinary shares under the second tranche of its buyback programme announced 31 July 2025. The shares were bought on 15 September 2025 on the London Stock Exchange/CBOE (UK)/CXE and the company intends to hold the purchased shares as treasury shares.
After settlement the company's registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 4,001,961 are held as treasury shares, leaving 8,948,351,687 ordinary shares with voting rights. The announcement points investors to a full trade breakdown at the provided link and to Haleon's investor website for details.
Haleon plc announced on 15 September 2025 that it purchased 997,991 ordinary shares of each under the second tranche of its share buyback programme announced 31 July 2025. Of the purchased shares, 23,788 will be cancelled and 974,203 will be held as treasury shares. After settlement the company's registered share capital is 8,952,353,648 ordinary shares of each, with 2,501,961 held as treasury shares and 8,949,851,687 shares with voting rights.
The announcement notes a full trade breakdown is available via the provided RNS link and on the company's investor website.
Haleon plc announced the purchase and cancellation of 273,737 ordinary shares of each under the second tranche of its share buyback programme. The trades reported relate to executions on 11 September 2025, totaling 273,737 shares with an average price shown as 364.1267 (per the trade breakdown). After settlement, registered share capital is 8,952,377,436 ordinary shares, with 1,527,758 held in treasury, leaving 8,950,849,678 ordinary shares with voting rights. The company provided a full breakdown of individual trades via a public link and noted the announcement does not constitute an offer for securities.
FAQ
What is the current stock price of HALEON PLC (HLNCF)?
